MFEC:PA:PA-Lyxor Core MSCI EMU (DR) UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 15.356

Change

+0.13 (+0.88)%

Market Cap

USD 0.48B

Volume

1.09K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.15 (-0.32%)

USD 55.57B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-2.70 (-0.52%)

USD 13.81B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-2.00 (-0.54%)

USD 12.91B
WRD:PA HSBC MSCI World UCITS ETF

-0.12 (-0.34%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.54 (+0.60%)

USD 9.42B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-4.25 (-0.96%)

USD 8.85B
WLD:PA Lyxor UCITS MSCI World D-EUR

-1.20 (-0.36%)

USD 7.98B
HHH:PA HSBC S&P 500 UCITS ETF

-0.25 (-0.48%)

USD 7.67B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.89B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

-0.30 (-0.36%)

USD 5.54B

ETFs Containing MFEC:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.47% 92% A 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.47% 92% A 80% B-
Trailing 12 Months  
Capital Gain 14.26% 82% B 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.26% 81% B- 77% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.89% 57% F 63% D
Dividend Return 9.89% 56% F 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.93% 75% C 88% B+
Risk Adjusted Return 124.65% 94% A 96% N/A
Market Capitalization 0.48B 62% D 67% D+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike